Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Producer, liability

They have selective action on limbic system and have little effect on other body systems. They help in improving the anxiety and stress related symptoms. They are widely used because of lower dependence producing liability and wide margin of safety. [Pg.99]

Camacho and Karlsson [8] have examined the thermal stability of recycled HDPE, PP and their blends in their discussion of environmental concerns and producers liability concerning the dispersal, collection and recycling of these polymers. [Pg.11]

Spence, A. Michael. (1977). "Consumer misperceptions, product failure and producer liability." Review of Economic Studies, vol. 44(3), pp. 561-572. [Pg.225]

An important and difficult task is concisely translating your requirements into study objectives. For example, if you need to decide between two methods of storing a hazardous chemical in a plant, the analysis objective should precisely define that what is needed is the relative difference between the methods, not the more general I want to know the risk of these two storage methods. And asking your QRA team for more than is necessary to satisfy your particular need is counterproductive and may create unnecessary liabilities. For any QRA to efficiently produce the necessary types of results, you must clearly communicate your requirements... [Pg.26]

Your process may produce wastes that cannot be treated on-site, and so must be transported off-site for treatment and disposal. Wastes of this type are usually non-aqueous liquids, sludge, or solids. Often, wastes for off-site disposal are costly to transport and to treat, and represent a third-party liability. Therefore, minimization of these wastes yields a direct cost benefit, both present and future. Measure the quantity and note the composition of any wastes associated with your process that need to be sent for off-site disposal. Record your results in a table or an appropriate spreadsheet. [Pg.376]

The life of the product- access to the records will probably not be needed for some considerable time, possibly long after the contract has closed. On defense contracts the contractor has to keep records for up to 20 years and for product liability purposes, in the worst case situation (taking account of appeals), you could be asked to produce records up to 17 years after you made the product. [Pg.501]

Inherent to the completion operation are the stimulation fluids used to carry sand or otherwise enhance producing qualities of the well. These stimulation fluids may or may not be toxic in nature. The stimulation fluids, while sometimes batch mixed at the service company s facility, may also be mixed on location. The latter system is preferable unless the service company is willing to let from the operator any liability common to the fluid in the case of excess. [Pg.1354]

The upshot of this trend toward visibility of research should reduce liability on the part of drug manufacturers and researchers, increase the likelihood that accuracy is enhanced, and produce more informed drug users. The question of accuracy undergirds the topic of liability, and if trends toward pharmacogenetics and individualized drug therapy hold, the importance of accuracy and subsequent liability will only increase. [Pg.722]

My own bias is toward the therapeutic potential. I do not care whether anything we develop produces euphoria or dependence potential. I think from the point of view of a drug abuse problem or a dependence liability that the alpha-ethyl probably does not have the reinforcing qualities and is not as pleasurable as MDMA. [Pg.22]

IkB kinase-p is a key regulatory enzyme in the NF-kB pathway, and inhibition of this enzyme has the potential for yielding treatments for inflammatory and autoimmune diseases. Morwick et al. [53] report on the optimization of a pM IKKp inhibitor with low aqueous solubility, moderate human liver microsome stability, and inhibition of several CYPs (3A4, 2C9, 1A2) with pM potencies. Modulation of the thiophene core (other thiophene isomer, pyrimidine and oxazole) produces compounds of similar potency to the hit. Fusing the 5-phenyl moiety to the thiophene to form a thieno[2,3-b]pyridine core increases aqueous solubility of the series as well as reduces the CYP liability. While the optimized compound still shows pM IKK(S potency, the aqueous solubility, HLM stability and CYP profiles are much improved. A pharmacophore model was generated that enabled scaffold hopping to yield this new chemotype (Scheme 7). [Pg.197]

Property damages and legal liabilities are not the only sources of financial impacts a company may suffer at the time of an incident. Business interruption losses will also occur since the facility will not longer be able to function as intended. Analysis of insurance industry claims data shows that business interruption losses are generally three times the amount of physical property damage. Often the justification for a safety feature may not be the loss of the component itself but of the impact to operations and loss revenue it produces. [Pg.6]

LIMIT OF LIABILITY/DISCLAIMER OF WARRANTY THE PUBLISHER AND AUTHOR HAVE USED THEIR BEST EFFORTS IN PREPARING THIS BOOK. THE PUBLISHER AND AUTHOR MAKE NO REPRESENTATIONS OR WARRANTIES WITH RESPECT TO THE ACCURACY OR COMPLETENESS OF THE CONTENTS OF THIS BOOK AND SPECIFICALLY DISCLAIM ANY IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. THERE ARE NO WARRANTIES WHICH EXTEND BEYOND THE DESCRIPTIONS CONTAINED IN THIS PARAGRAPH. NO WARRANTY MAY BE CREATED OR EXTENDED BY SALES REPRESENTATIVES OR WRITTEN SALES MATERIALS. THE ACCURACY AND COMPLETENESS OF THE INFORMATION PROVIDED HEREIN AND THE OPINIONS STATED HEREIN ARE NOT GUARANTEED OR WARRANTED TO PRODUCE ANY PARTICULAR RESULTS, AND THE ADVICE AND STRATEGIES CONTAINED HEREIN MAY NOT BE SUITABLE FOR EVERY INDIVIDUAL. NEITHER THE PUBLISHER NOR AUTHOR SHALL BE LIABLE FOR ANY LOSS OF PROFIT OR ANY OTHER COM-MERCIAL DAMAGES, INCLUDING BUT NOT LIMITED TO SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR OTHER DAMAGES. ... [Pg.4]

In the early 1960s, drug companies began to lobby for government indemnity for the vaccines they developed, tested, and produced. Because so many people are vaccinated at one time, particularly school-age children, ADRs from a vaccine can carry considerable liability. As more diseases have become vaccine-preventable, more ADRs have been reported. In 1974, impetus for indemnity increased when the courts upheld a jury verdict of 200,000 for a child who developed polio from the Sabin live-polio vaccine. ... [Pg.493]


See other pages where Producer, liability is mentioned: [Pg.282]    [Pg.133]    [Pg.134]    [Pg.97]    [Pg.282]    [Pg.133]    [Pg.134]    [Pg.97]    [Pg.11]    [Pg.263]    [Pg.1121]    [Pg.161]    [Pg.207]    [Pg.111]    [Pg.120]    [Pg.127]    [Pg.143]    [Pg.263]    [Pg.417]    [Pg.518]    [Pg.38]    [Pg.39]    [Pg.131]    [Pg.10]    [Pg.10]    [Pg.86]    [Pg.103]    [Pg.483]    [Pg.265]    [Pg.362]    [Pg.916]    [Pg.923]    [Pg.190]    [Pg.200]    [Pg.204]    [Pg.364]    [Pg.153]    [Pg.859]    [Pg.15]    [Pg.15]    [Pg.571]   
See also in sourсe #XX -- [ Pg.24 ]




SEARCH



Liability

© 2024 chempedia.info